ロード中...
Measuring differential treatment benefit across marker specific subgroups: the choice of outcome scale
Clinical and epidemiological studies of anticancer therapies increasingly seek to identify predictive biomarkers to obtain insights into variation in treatment benefit. For time to event endpoints, a predictive biomarker is typically assessed using the interaction between the biomarker and treatment...
保存先:
| 出版年: | Contemp Clin Trials |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5568905/ https://ncbi.nlm.nih.gov/pubmed/28254404 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cct.2017.02.007 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|